CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.
Guan Y, Ma Y, Li Q, Sun Z, Ma L, Wu L, Wang L, Zeng L, Shao Y, Chen Y, Ma N, Lu W, Hu K, Han H, Yu Y, Huang Y, Liu M, Li D.
Guan Y, et al. Among authors: sun z.
EMBO Mol Med. 2016 May 2;8(5):477-88. doi: 10.15252/emmm.201506039. Print 2016 May.
EMBO Mol Med. 2016.
PMID: 26964564
Free PMC article.